The FDA announced on October 14, 2026, that Fresenius Medical Care Renal Therapies Group, LLC is recalling DELFLEX Peritoneal Dialysis Solution due to a lack of sterility assurance. The agency stated the recall addresses potential leaks from small perforations in the print area of the primary bag.
How to tell if you have it
- Brand: Fresenius Medical Care
- Product: DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set
- Size: 2,500 mL Single dose bag
- CAT.NO.: 054-25324
- NDC: 46163-212-94
- Lot code: 25NGPD001
- Expiration date: 4/30/2027
The hazard
According to the FDA, complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots. The recall is classified as a Class II recall due to this lack of sterility assurance.
Context
GovInfoNow's records show Fresenius Medical Care Renal Therapies Group, LLC has 16 other recalls on record since September 29, 2017. Other recent recalls of similar products include Fresenius Medical Care 5008X HD/HDF with CLiC Blood Tubing Set Recall (August 10, 2026), Fresenius Medical Care CombiSet Hemodialysis Tubing Set Recall (July 29, 2026), and Fresenius Medical Care GRANUFLO Dry Acid Concentrate Recall (July 14, 2026). Other recent recalls of similar products include Fresenius Recalls DELFLEX Dialysis Bags Due to Sterility Risk (April 6, 2026), Fresenius DELFLEX Peritoneal Dialysis Solution Recall (April 6, 2026), and Fresenius Kabi 5% Dextrose Injection Recall (March 11, 2026).